US Stock MarketDetailed Quotes

NEO NeoGenomics

Watchlist
  • 15.400
  • -0.230-1.47%
Close May 14 16:00 ET
  • 15.300
  • -0.100-0.65%
Post 18:47 ET
1.97BMarket Cap-23333P/E (TTM)

About NeoGenomics Company

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials and research. It also provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Company Profile

SymbolNEO
Company NameNeoGenomics
Listing DateDec 10, 2012
Founded1998
CEOMr. Christopher M. Smith
MarketNASDAQ
Employees2100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address9490 NeoGenomics Way
CityFort Myers
ProvinceFlorida
CountryUnited States of America
Zip Code33912
Phone1-239-768-0600
Websitehttp://www.neogenomics.com

Company Executives

  • Name
  • Position
  • Salary
  • Christopher M. Smith
  • Chief Executive Officer and Director
  • 11.67M
  • Shashikant Kulkarni
  • Chief Scientific Officer and Executive Vice President, Research and Development
  • --
  • Warren Stone
  • Chief Commercial Officer
  • 3.01M
  • Melody Harris
  • Chief Operations Officer and President, Informatics
  • 4.69M
  • Jeffrey S. Sherman
  • Chief Financial Officer
  • 3.55M
  • Cynthia J. Dieter
  • Chief Accounting Officer and Controller
  • --
  • Gregory D. Aunan
  • Senior Vice President and Chief Accounting Officer
  • --
  • Alicia C. Olivo
  • Executive Vice President, Business Development, General Counsel and Corporate Secretary
  • --
  • Vishal Sikri
  • President, Advanced Diagnostics
  • 2.37M
  • Lynn A. Tetrault
  • Chairman of the Board
  • 365.00K
  • Elizabeth A. Floegel
  • Independent Director
  • 273.39K
  • Dr. Neil Gunn
  • Independent Director
  • 276.31K
  • Stephen M. Kanovsky
  • Independent Director
  • 309.20K
  • Dr. Alison L. Hannah, M.D.
  • Independent Director
  • 65.00K
  • Bruce K. Crowther
  • Independent Director
  • 313.45K
  • Michael A. Kelly
  • Independent Director
  • 317.50K
  • David B. Perez
  • Independent Director
  • 309.80K
  • Anthony P. Zook
  • Independent Director
  • 276.31K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg